Natural Killer (NK) cells mediate graft versus leukemia effects after allogeneic hematopoietic cell transplantation (allo-HCT) by the production of inflammatory cytokines and by direct target lysis.
Introduction
Natural killer (NK) cells are innate immune effectors that directly lyse virally-infected or malignant cells. They also release cytokines (IFNγ, GM-CSF) and chemokines (MIP-1α, MIP-1β, IL-8 and RANTES) that modulate the adaptive immune system and hematopoiesis. NK cells directly activate antigen presenting cells, which provide reciprocal activation of NK cells. As the first donor-derived lymphocyte subset to reconstitute following hematopoietic cell transplantation (HCT), NK cells may play a pivotal role in the graft versus leukemia (GvL) effect, especially in myeloid leukemia [1] [2] . However, it is not known which function (killing or cytokine production) is physiologically most important to mediate clinical responses, or whether these functions recover with different kinetics early after transplantation.
NK cells express a variety of surface receptors that either positively or negatively modulate their function. NK cell activation is determined by the net balance of both inhibitory and activating signals it receives through these surface receptors [3] [4] [5] . The inhibitory receptor families include the killer cell immunoglobulin-like receptors (KIR), which recognize allelic epitopes present on the classical class I human leukocyte antigen (HLA) molecules HLA-A, HLA-B and HLA-C, and CD94/NKG2A, which recognizes the non-classical class I HLA molecule HLA-E [6] [7] . Interaction with target cells that lack "self" HLA molecules to signal via inhibitory receptors results in NK cell activation 8 . Activating signals, which can potentially override inhibitory signalling, are mediated by receptor families including activating KIR, CD94/NKG2C, NKG2D, the natural cytotoxicity receptors (NKp30, NKp44 and NKp46), CD16 and CD244 4 .
The clinical application of NK cell-mediated therapy has focused on the role of the inhibitory KIR family and on ways to increase the frequency of alloreactive NK cells after HCT. In the setting of a potently T-cell depleted haploidentical HCT, grafts from donors with NK cells expressing KIR that are not inhibited by recipient HLA-ligands are associated with decreased relapse and
For personal use only. on October 24, 2017. by guest www.bloodjournal.org From 4 prolonged survival 1 . In addition, non-T-cell depleted grafts from adult unrelated donors (URD) with favorable KIR genotypes can confer similar beneficial clinical effects, with less relapse and increased survival 9 , supporting the importance of NK cells in mediating outcome of HCT.
The acquisition of both cytokine-producing and cytotoxic functions occurs during NK cell development through a process commonly referred to as licensing or NK cell education [10] [11] .
While the exact timing and location of NK cell education is unknown, it is generally believed that NK cells acquire function following engagement of inhibitory receptors with self-ligand after their differentiation from hematopoietic progenitors 10, 12 . NK cells lacking inhibitory receptors for self do exist, but they remain hyporesponsive and are considered "uneducated" [12] [13] [14] . In the early stages of the NK cell developmental pathway, stage III cells, which are defined in part by the absence of MHC-specific receptors, lack both cytotoxicity and cytokine production. Upon acquisition of the CD94/NKG2A heterodimer, stage III cells transition to stage IV, or CD56 bright NK cells, at which time they acquire the capacity to produce IFNγ following stimulation with IL-12, IL-15 and IL-18 15 . Still, they display low cytotoxic potential 16 . Only upon further development and emigration from the lymph node to the periphery do NK cells acquire CD16 and KIR and become highly cytotoxic 17 .
Allo-HCT provides a unique environment in which to study human NK cell education as it recapitulates NK cell development from hematopoietic stem cells in a short interval. It is unknown whether the acquisition of the cytotoxic and cytokine-producing functions occurs in parallel through interactions with inhibitory receptors or if distinct signals are required to generate each effector function. To understand the acquisition of NK cell function early after allo-HCT, we developed a 9-color flow cytometric-based assay to simultaneously measure both
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Materials and Methods

Patients and Samples
We analyzed peripheral blood mononuclear cells (PBMCs) from 46 Fourteen acute myelogenous leukemia patients received adult donor HLA-partially matched Tcell depleted (CD34 + selected) grafts with no post-transplant immunosuppression. Additional samples from 10 patients who received double unit umbilical cord blood (UCB) transplants using cyclosporine and mycophenolate mofetil GvHD prophylaxis were analysed 18 . We collected pre-HCT donor samples and recipient samples at 1 month (T-cell replete and UCB only), 3 months (± 10 days) and 6 months (± 10 days) post-HCT. Samples were obtained after informed consent in accordance with the Declaration of Helsinki and approval from the National Marrow Donor 
Target Cells and Cytokine Stimulation
The human erythroleukemia cell line K562 was maintained in Iscove's modified Dulbecco's medium (Cellgro) supplemented with 10% FBS (Invitrogen) and 100 U/mL penicillin and 100 U/mL streptomycin (both Invitrogen). For cytokine stimulation, recombinant human IL-12 (10ng/mL) and recombinant human IL-18 (100ng/mL) (both R&D Systems) was added to 0.5 x 10 6 -1 x 10 6 PBMCs and incubated overnight before being used in the CD107a and IFNγ assay. For low dose IL-15 stimulation, 1 x 10 6 /mL PBMC were incubated overnight with 1 ng/mL recombinant human IL-15 (R&D Systems).
CD107a and IFNγ Assay
PBMCs (4 x 10 6 /mL) were mixed with K562 cells at a ratio of 2:1 in a final volume of 200μL in vbottomed 96 well plates in the absence of exogenous cytokines. Anti-CD107a-PerCP-Cy5.5
(clone H4A3, Biolegend) was added to each well and incubated for 1 hour at 37°C, 5% CO 2 .
After 1 hour, Brefeldin A (Golgi Plug, BD Biosciences) and monensin (Golgi Stop, BD Biosciences) were added to each well and the cells were incubated for an additional 3 hours.
Although CD107a degranulation can be detected after 2 hours, we selected a 4-hour time point readout for this assay to optimally detect simultaneous IFNγ production, which takes longer to 
Statistical Analysis
For comparisons between independent groups, the Wilcoxon rank sum test was used. For comparisons of matched samples, the Wilcoxon signed rank test was used unless otherwise indicated in the figure legend. For comparisons of multiple groups where multiple measurements were taken on the same sample, a linear mixed model was used, assuming an exchangeable correlation structure for the correlated measurement errors among repeated measures. Linear correlation was analysed using the Pearson correlation coefficient. Variables are summarized with mean and standard error (mean ± SEM). Statistical significance was indicated as *P<0.05, **P<0.01, ***P<0.0001, or ns for P≥0.05. Statistical analyses were performed using SAS version 9.2 (SAS Institute, Cary, NC).
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Results
Target cell-induced IFNγ production is decreased after allogeneic transplantation
To assess NK cell function, we developed a novel assay to simultaneously evaluate degranulation of CD56 + CD3 -NK cells (using CD107a expression as a surrogate marker for cytotoxicity 19 ) and cytokine production (intracellular IFNγ expression). Healthy donor samples were compared to samples from patients receiving adult URD unmanipulated (T-cell replete), adult URD T-cell depleted (T-cell deplete) or UCB grafts. These dual NK cell functions were Although some have proposed that NK cell function may be more robust in the absence of T-cell competition for cytokines 20 , our data suggests a T-cell dependent effect on the acquisition of degranulating capacity. Interestingly, compared to normal donors, the degranulation response to K562 targets was significantly higher at 3 months post-UCB transplant (54%±3% vs. 40%±2%; p= 0.004). This difference persisted at 6 months post-HCT.
In marked contrast to degranulation activity, the target cell-induced IFNγ production by NK cells 
KIR expression distinguishes NK cells capable of producing IFNγ
NK cell function develops following engagement of inhibitory receptors (KIR and/or NKG2A) with "self" HLA 12 , and the small KIR -NKG2A -cell subset remains functionally hyporesponsive [12] [13] [14] . We This suggests that NK cells expressing more than one self-recognizing inhibitory receptor are more responsive to activation for degranulation 22, [28] [29] [30] . Cytokine-induced IFNγ production was predominantly confined to NKG2A-expressing cells, which includes the CD56 bright subset.
As was seen with donor cells, NK cells from post-HCT recipients lacking both KIR and NKG2A
had low CD107a expression and were poor producers of IFNγ ( 
KIR expression correlates with IFNγ production
After allo-HCT the expression of KIR is decreased and expression of NKG2A is increased; the inverse of what is seen in healthy donors [24] [25] . To test whether KIR expression correlates with target-induced IFNγ production we compared the K562 target-induced IFNγ production in NK For personal use only. on October 24, 2017. by guest www.bloodjournal.org From
Discussion
We have identified marked differences in the recovery of target cell induced functions after allo-HCT from three cohorts with variable T-cell graft content. IFNγ production was diminished after all types of HCT, and degranulation was impaired only after T-cell deplete HCT. We have shown that both KIR expression and education via cognate KIR ligand are required for target cellinduced IFNγ production by NK cells reconstituting post-HCT. Target-induced where they were likely to exhibit both degranulation and cytokine production in response to targets. They proposed that the threshold for inhibitory signalling required for NK cells to acquire degranulation function is much lower than the threshold required for NK cells to become cytokine producers. They observed that all cytokine-producing NK cells were able to degranulate, as we found in the human donor and post-HCT samples. We postulate that in the post-HCT setting, the interaction between NKG2A and its ligand HLA-E supports the education For personal use only. on October 24, 2017. by guest www.bloodjournal.org From of NK cells to degranulate, but that the signal is too weak to meet the required threshold to educate for cytokine production.
It has been proposed that T-cells present in grafts compete with NK cells for cytokines, thus inhibiting the emergence of the alloreactive NK cells that mediate GvL 20 . Strikingly, we found that recipients of T-cell replete (unmanipulated) grafts had better overall NK cell function than did recipients of T-cell depleted grafts or UCB grafts, which contain naïve T-cells. Not only was NK cell function increased early post-HCT with T-cell replete grafts, but NKG2A expression was decreased and KIR expression was increased. While these results differ from our previous report showing that KIR expression was more suppressed after T-cell replete HCT 25 they can be explained by the differences in the settings tested. In the cohort reported here, the T-cell depletion was performed using CD34 selection, which eliminates nearly all contaminating T- 
